Bifidobacterium bifidum PRL2010
Names | Bifidobacterium bifidum PRL2010 |
---|---|
Accession numbers | NC_014638 |
Background | Bifidobacteria represent an important group of the intestinal microbiota of humans and are believed to be promising candidates for pharmaceutical applications and functional food products due to their ability to exclude intestinal pathogens, strengthen the intestinal barrier, and/or modulate the immune response in the intestine. Bifidobacterium bifidum (strain PRL2010) is a anaerobic Gram-positive bacterium isolated from infant stool and is used as a probiotic to maintain healthy gut flora. It revealed a nutrient-acquisition strategy that targets host-derived glycans, such as those present in mucin. Proteome and transcriptome profiling revealed a set of chromosomal loci responsible for mucin metabolism that appear to be under common transcriptional control and with predicted functions that allow degradation of various O-linked glycans in mucin. Conservation of the latter gene clusters in various B. bifidum strains supports the notion that host-derived glycan catabolism is an important colonization factor for B. bifidum with concomitant impact on intestinal microbiota ecology. (Adapted from PMID: 20974960). (EBI Integr8) |
Taxonomy | |
Kingdom: | Bacteria |
Phylum: | Actinobacteria |
Class: | Actinobacteria |
Order: | Bifidobacteriales |
Family: | Bifidobacteriaceae |
Genus: | Bifidobacterium |
Species: | bifidum |
Strain | PRL2010 |
Complete | Yes |
Sequencing centre | (02-NOV-2010) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA (12-NOV-2009) Department of Genetics, Biology of Microorganisms, Anthropology and Evolution, University of Parma, |
Sequencing quality | Level 6: Finished |
Sequencing depth | NA |
Sequencing method | 454-GS-FLX |
Isolation site | human feces in Korea |
Isolation country | Korea |
Number of replicons | 1 |
Gram staining properties | Positive |
Shape | Bacilli |
Mobility | No |
Flagellar presence | No |
Number of membranes | 1 |
Oxygen requirements | Anaerobic |
Optimal temperature | NA |
Temperature range | Mesophilic |
Habitat | HostAssociated |
Biotic relationship | Free living |
Host name | Homo sapiens |
Cell arrangement | NA |
Sporulation | Nonsporulating |
Metabolism | NA |
Energy source | NA |
Diseases | NA |
Pathogenicity | No |
Glycolysis / Gluconeogenesis
Citrate cycle (TCA cycle)
Pentose phosphate pathway
Galactose metabolism
Purine metabolism
Pyrimidine metabolism
Alanine, aspartate and glutamate metabolism
Glycine, serine and threonine metabolism
Cysteine and methionine metabolism
Valine, leucine and isoleucine biosynthesis
Lysine biosynthesis
Histidine metabolism
Phenylalanine, tyrosine and tryptophan biosynthesis
Selenocompound metabolism
D-Glutamine and D-glutamate metabolism
D-Alanine metabolism
Streptomycin biosynthesis
Peptidoglycan biosynthesis
C5-Branched dibasic acid metabolism
One carbon pool by folate
Thiamine metabolism
Vitamin B6 metabolism
Nicotinate and nicotinamide metabolism
Pantothenate and CoA biosynthesis
Folate biosynthesis
Terpenoid backbone biosynthesis
Aminoacyl-tRNA biosynthesis
Citrate cycle (TCA cycle)
Pentose phosphate pathway
Galactose metabolism
Purine metabolism
Pyrimidine metabolism
Alanine, aspartate and glutamate metabolism
Glycine, serine and threonine metabolism
Cysteine and methionine metabolism
Valine, leucine and isoleucine biosynthesis
Lysine biosynthesis
Histidine metabolism
Phenylalanine, tyrosine and tryptophan biosynthesis
Selenocompound metabolism
D-Glutamine and D-glutamate metabolism
D-Alanine metabolism
Streptomycin biosynthesis
Peptidoglycan biosynthesis
C5-Branched dibasic acid metabolism
One carbon pool by folate
Thiamine metabolism
Vitamin B6 metabolism
Nicotinate and nicotinamide metabolism
Pantothenate and CoA biosynthesis
Folate biosynthesis
Terpenoid backbone biosynthesis
Aminoacyl-tRNA biosynthesis